- Home
- APLT vs OWLT Comparison
APLT vs OWLT Comparison
Compare APLT & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- OWLT
- Stock Information
- Founded
- APLT 2016
- OWLT 2013
- Country
- APLT United States
- OWLT United States
- Employees
- APLT N/A
- OWLT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- APLT Health Care
- OWLT Health Care
- Exchange
- APLT Nasdaq
- OWLT Nasdaq
- Market Cap
- APLT 178.6M
- OWLT 148.6M
- IPO Year
- APLT 2019
- OWLT N/A
- Fundamental
- Price
- APLT $1.30
- OWLT $9.79
- Analyst Decision
- APLT Buy
- OWLT
- Analyst Count
- APLT 5
- OWLT 0
- Target Price
- APLT $4.13
- OWLT N/A
- AVG Volume (30 Days)
- APLT 5.5M
- OWLT 156.1K
- Earning Date
- APLT 11-10-2025
- OWLT 11-12-2025
- Dividend Yield
- APLT N/A
- OWLT N/A
- EPS Growth
- APLT N/A
- OWLT N/A
- EPS
- APLT N/A
- OWLT N/A
- Revenue
- APLT $121,000.00
- OWLT $89,774,000.00
- Revenue This Year
- APLT N/A
- OWLT $28.93
- Revenue Next Year
- APLT $5,935.35
- OWLT $22.82
- P/E Ratio
- APLT N/A
- OWLT N/A
- Revenue Growth
- APLT N/A
- OWLT 36.78
- 52 Week Low
- APLT $0.30
- OWLT $2.75
- 52 Week High
- APLT $10.62
- OWLT $10.30
- Technical
- Relative Strength Index (RSI)
- APLT 62.38
- OWLT 64.62
- Support Level
- APLT $1.16
- OWLT $8.88
- Resistance Level
- APLT $1.50
- OWLT $9.63
- Average True Range (ATR)
- APLT 0.15
- OWLT 0.65
- MACD
- APLT -0.01
- OWLT 0.06
- Stochastic Oscillator
- APLT 66.64
- OWLT 95.82
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About OWLT Owlet Inc.
Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.